Novocure Limited logo

Novocure Limited (NVCR)

$16.88

Novocure Limited (NVCR) Share Price Forecast
Currently 13 wall-street analysts regularly analyze the financials of Novocure Limited on a frequent basis to provide recommendations along with target share price. 13 analysts offering 12-month price forecasts for Novocure Limited (NVCR) have a share price target of $27.17. This median of share price forecast represents a 60.96% upside from the latest price of $16.88 as on 07.09.24.

Novocure Limited (NVCR) Price vs Consensus Price Target

Price
Target Price
As per the chart shown above, analysts believe that the Novocure Limited (NVCR) share price will touch around $27.17 in next 12-months.
Novocure Limited (NVCR) Share Price Forecast v/s Share Price Today
Below is a chart showing the percentage difference between Novocure Limited's share price and its median forecast price. As on 07.09.24, the difference is -21.24%

Novocure Limited (NVCR): Difference between Current Price & Median Forecasted Price

Difference in Percentage terms
Novocure Limited (NVCR) Share Price : Analyst Recommendation
Based on 13 analysts tracking and researching Novocure Limited (NVCR) share have buy recommendation on an average.

3M Ago1M AgoCurrent
Buy
5
5
5
Outperform
3
3
3
Hold
5
5
5
Underperform
0
0
0
Sell
0
0
0
Novocure Limited (NVCR) Share Price Technical Analysis

50 Day Moving Average v/s Current Share Price

Moving Average
Price

200 Day Moving Average v/s Current Share Price

Moving Average
Price

FAQs

The latest share price target for Novocure Limited (NVCR) is $27.17, offered by 13 analysts offering 12-month price forecasts.

Novocure Limited (NVCR) has a maximum of 0.61 upside potential, based on 13 analysts offering 12-month price forecasts.

Based on 13 analysts tracking and researching Novocure Limited (NVCR), 61.54% have a buy recommendation. Remaining 38.46% have either sell or hold recommendations.

The latest share price of Novocure Limited (NVCR) is $16.88 as of 07/09/2024.

8 of total 13 analysts offering stock ratings for Novocure Limited NVCR have recommended buy rating.